Figure 1. Effect of VitE (150mg/kg) and DEX (0.125mg/kg) on (A) VCL-reduced testicular weight (TW) to body weight (BW) ratio; (B) VCL-decreased body weight; (C) VCL-declined testicular level of ALP; and (D) VCL-decreased serum level of testosterone; the VitE and DEX co-administration managed to significantly (P<0.05) recover the VCL-induced derangements.
